Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-24

Clinical Trial Update: Effect of Oral Supplementation With Curcumin (Turmeric) in Patients With Proteinuric Chronic Kidney Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating oral curcumin supplementation in proteinuric chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curcumin (curcumin)

Snippet

Sponsor: Instituto Nacional de Cardiologia Ignacio Chavez | Conditions: Proteinuria | Phase 3 | Status: COMPLETED